-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tiragolumab in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tiragolumab in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tiragolumab in Metastatic Hepatocellular Carcinoma (HCC) Drug Details: Tiragolumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Ovarian Cancer Drug Details: Palbociclib (Ibrance, Agatha) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Inavolisib in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Inavolisib in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Inavolisib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGB-3245 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BGB-3245 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BGB-3245 in Colorectal Cancer Drug Details: BGB-3245 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BSI-060T in Thyroid Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BSI-060T in Thyroid Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BSI-060T in Thyroid Cancer Drug Details: BSI-060T is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGB-16673 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BGB-16673 in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BGB-16673 in Mantle Cell Lymphoma Drug Details: BGB-16673 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BWC-0977 in Pseudomonas aeruginosa Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BWC-0977 in Pseudomonas aeruginosa Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BWC-0977 in Pseudomonas aeruginosa Infections Drug Details: BWC-0977 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vixarelimab in Prurigo
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vixarelimab in Prurigo report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vixarelimab in Prurigo Drug Details: Vixarelimab (KPL-716) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Inavolisib in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Inavolisib in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Inavolisib in Solid Tumor Drug Details: Inavolisib (GDC-0077) is under development...